Drug Development Linked More Closely to Diagnostics

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.

Related Content:

FormulationProcess ValidationQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-10-02-2004
The European Commission Approves Severe Alopecia Areata Treatment
EC Approves Fixed-Dose Oral Combination Treatment for AML
Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines